The effect of Riluzole on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial.

Trial Profile

The effect of Riluzole on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2015

At a glance

  • Drugs Riluzole (Primary) ; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Sep 2015 Status changed from active, no longer recruiting to completed.
    • 04 Jul 2012 Planned end date changed from 23 Sep 2013 to 23 Jun 2012 as reported by Iranian Registry of Clinical Trials.
    • 04 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top